Robert Holloway, MD to Have Manuscript Published in the Oncologist

Choose the health content that's right for you, and get it delivered right in your inbox

Dr. Robert Holloway’s manuscript titled, “Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination With Carboplatin Versus Gemcitabine/Carboplatin for the Treatment of Platinum Sensitive Recurrent Ovarian Cancer: A Systematic Review,” has been accepted for publication by The Oncologist- The official journal of the Society for Translational Oncology. This manuscript was reviewed by Section Editors at The Oncologist and other external experts in the field.

Congratulations to Dr. Holloway for the scientific advancement that this manuscript represents.

Tuesday, October 25, 2011

Recent Blogs

Two ladies talking while wearing masks
Blog
How to Respond When a Loved One is Hesitant About the COVID-19 Vaccine
A pregnant woman looking at lab results in her doctor's office
Blog
Pregnancy and the COVID-19 Vaccine
Blog
Healing From Hernias Faster with Robotic Surgery
The waiting room of Dr. Patel's new clinic
Blog
Dr. Patel’s Clinic Relocates
Blog
Dr. Patel Featured on WFTV Facebook Live
View More Articles